Hans Van Houte Nurix Therapeutics, Inc. (NRIX) insider trading activity

NRIX Quotes by TradingView

Hans Van Houte is Chief Financial Officer of Nurix Therapeutics, Inc.. Currently has a direct ownership of 37,592 shares of NRIX, which is worth approximately $462,757. The most recent transaction as insider was on Nov 03, 2025, when has been sold 6,284 shares (Common Stock) at a price of $12.56 per share, resulting in proceeds of $78,927. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 37.6K
5.86% 3M change
11.47% 12M change
Total Value Held $462,757

Hans van Houte Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 03 2025
SELL
Open market or private sale
$78,927 $12.56 p/Share
6,284 Reduced 14.32%
37,592 Common Stock
Oct 30 2025
SELL
Open market or private sale
$40,064 $12.8 p/Share
3,130 Reduced 6.66%
43,876 Common Stock
Oct 30 2025
BUY
Exercise of conversion of derivative security
-
11,494 Added 19.65%
47,006 Common Stock
Aug 01 2025
SELL
Open market or private sale
$59,584 $11.03 p/Share
5,402 Reduced 13.2%
35,512 Common Stock
Jul 30 2025
SELL
Open market or private sale
$51,691 $12.01 p/Share
4,304 Reduced 9.52%
40,914 Common Stock
Jul 30 2025
BUY
Exercise of conversion of derivative security
-
11,494 Added 20.27%
45,218 Common Stock
May 02 2025
SELL
Open market or private sale
$70,223 $11.33 p/Share
6,198 Reduced 15.53%
33,724 Common Stock
Apr 30 2025
SELL
Open market or private sale
$28,037 $11.5 p/Share
2,438 Reduced 5.76%
39,922 Common Stock
Apr 30 2025
BUY
Exercise of conversion of derivative security
-
8,636 Added 16.93%
42,360 Common Stock
Mar 03 2025
SELL
Open market or private sale
$86,035 $14.77 p/Share
5,825 Reduced 14.73%
33,724 Common Stock
Jan 30 2025
SELL
Open market or private sale
$56,416 $20.07 p/Share
2,811 Reduced 6.64%
39,549 Common Stock
Jan 30 2025
BUY
Exercise of conversion of derivative security
-
8,636 Added 16.93%
42,360 Common Stock
Nov 01 2024
SELL
Open market or private sale
$86,096 $24.28 p/Share
3,546 Reduced 9.51%
33,724 Common Stock
Oct 30 2024
SELL
Open market or private sale
$57,542 $24.3 p/Share
2,368 Reduced 5.97%
37,270 Common Stock
Oct 30 2024
BUY
Exercise of conversion of derivative security
-
8,636 Added 17.89%
39,638 Common Stock
Aug 26 2024
SELL
Open market or private sale
$504,400 $25.22 p/Share
20,000 Reduced 39.21%
31,002 Common Stock
Aug 01 2024
SELL
Open market or private sale
$75,902 $21.83 p/Share
3,477 Reduced 6.38%
51,002 Common Stock
Jul 30 2024
SELL
Open market or private sale
$51,468 $20.67 p/Share
2,490 Reduced 4.37%
54,479 Common Stock
Jul 30 2024
BUY
Exercise of conversion of derivative security
-
8,636 Added 13.16%
56,969 Common Stock
Jun 20 2024
SELL
Open market or private sale
$400,200 $20.01 p/Share
20,000 Reduced 29.27%
48,333 Common Stock
May 02 2024
SELL
Open market or private sale
$44,892 $12.83 p/Share
3,499 Reduced 4.87%
68,333 Common Stock
Apr 30 2024
SELL
Open market or private sale
$16,699 $12.04 p/Share
1,387 Reduced 1.89%
71,832 Common Stock
Apr 30 2024
BUY
Exercise of conversion of derivative security
-
4,886 Added 6.26%
73,219 Common Stock
Feb 16 2024
SELL
Open market or private sale
$68,256 $10.02 p/Share
6,812 Reduced 9.07%
68,333 Common Stock
Jan 30 2024
SELL
Open market or private sale
$13,351 $7.99 p/Share
1,671 Reduced 2.18%
75,145 Common Stock
HvH

Hans Van Houte

Chief Financial Officer
San Francisco, CA

Track Institutional and Insider Activities on NRIX

Follow Nurix Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NRIX shares.

Notify only if

Insider Trading

Get notified when an Nurix Therapeutics, Inc. insider buys or sells NRIX shares.

Notify only if

News

Receive news related to Nurix Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on NRIX